The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen

Journal of Urology

Volumn 165, Issue 1, 2001, Pages 294-300

  Urban, D ^a   Irwin, W ^a   Kirk, M ^a   Markiewicz, M A ^a   Myers, R ^a   Smith, M ^a   Weiss, H ^a   Grizzle, W E ^a   Barnes, S ^a  

^a UNIVERSITY OF ALABAMA HOSPITAL   (United States)

Author keywords

Biological markers; Isoflavones; Prostate; Prostate specific antigen; Soy proteins

Indexed keywords

BIOCHEMICAL MARKER; DAIDZEIN; GENISTEIN; ISOFLAVONE; PROSTATE SPECIFIC ANTIGEN; SOYBEAN PROTEIN;

ADULT; ADVANCED CANCER; AGED; ANTIGEN SPECIFICITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIETARY INTAKE; DRUG BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ISOLATION; PROTO ONCOGENE; URINALYSIS; URINE VOLUME;

EID: 0034749288     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200101000-00082     Document Type: Article

References (26)

1. Cancer statistics, 1996
2. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii
3. A case-control study of prostatic cancer with reference to dietary habits
4. Genistein, daidzein, and their β-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets
5. Adenocarcinoma of the prostate
6. Soy intake and cancer risk: A review of in vitro and in vivo data
7. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture
8. Genistein, a component of soy, inhibits the expression of the EGF and ErbB/Neu receptors in the rat dorsolateral prostate
9. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats
10. Genistein and biochanin A inhibit the growth of human prostate cancer cells, but not epidermal growth factor receptor tyrosine auto-phosphorylation
11. Isoflavones and their conjugates in soy foods: Extraction conditions and analysis by HPLC-mass spectrometry
12. Elevated serum levels of p105erbb-2 in patients with advanced stage prostatic adenocarcinoma
13. Analysis of plasma isoflavones by reversed-phase hplc-multiple reaction ion monitoring-mass spectrometry
14. HPLC-mass spectrometry analysis of isoflavones
15. Meta-analysis of the effects of soy protein intake on serum lipids
16. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
17. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies
18. Isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice
19. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic
20. Intake of soy protein and soy protein extracts influences lipid metabolism and hepatic gene expression in gerbils
21. Soy protein and cardiovascular disease: The impact of bioactive components in soy
22. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP
23. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
24. Phytoestrogens and prostate cancer: Possible preventive role